Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q3 Loss of $0.37

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) reported Q3 EPS of ($0.37), versus ($0.43) reported last year.

For earnings history and earnings-related data on Cyclacel Pharmaceuticals, Inc. (CYCC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Linde (LIN) PT Lowered to $563 at Bernstein SocGen Group
• Macy's (M) Stock: Street Underestimates Earnings Pressure From Share Loss, Says Analyst